Blu Biotech is a US based medical diagnostics company founded in 2019 which has developed BREATHGUARD, the first micro gas chromatography based test to noninvasively detect various illnesses using exhaled breath to locate identified volatile organic compounds.
Blu Biotech Inc was initially formed to advance certain bioengineering innovations developed at the University of Michigan and to commercialize these technologies globally. Clinical sites exist in Michigan, New Mexico and Bari, Italy.
Research Team Awarded $2M NIH Grant for Breath Analyzer that Detects and Monitors COVID-19, COVID-19 Induced Lung Injury
U-M Weil Institute, College of Engineering & Michigan Medicine Awarded $5.7M Grant for Wearable Sensor that Detects Diseases through Body Odor